A bullet type of cancer killer under development

Published: 2004-07-28 06:58:00

Updated: 2004-07-28 06:58:00

Korea Bio Engineering Research Institute and Choongwe Pharm. Co. made an agreement on July 27 for the research and development of an anti-cancer drug, a new conceptional anti-cancer drug that blocks cancer cell's proliferation, and for the exchange of technology informations between two sides.

The mode of this new compound as an anti-angiogenesis selectively blocks new generation of blood v...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.